Sía eftir: Last updated date SelectEftirFyrirFrom - To Date Lokadagsetning This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorPRIMEParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Niðurstöður (3828) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank First vaccine to protect older adults from respiratory syncytial virus (RSV) infection 26 apríl 2023NewsHumanMedicinesVaccines EMA business hours over King's Day and Labour Day, 27 April and 1 May 25 apríl 2023NewsHumanCorporate European Immunization Week 2023: Statement by Executive Director Emer Cooke - Routine vaccination matters! Every dose counts to stay protected 24 apríl 2023NewsHumanVaccines Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 18-20 April 2023 21 apríl 2023NewsVeterinaryMaximum residue limitMedicines Single-arm trials as pivotal evidence for the authorisation of medicines in the EU 21 apríl 2023NewsHumanData on medicinesMedicines Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 11-14 April 2023 14 apríl 2023NewsHumanPharmacovigilanceReferrals Reducing risks to human and animal health from exposure to N-methyl pyrrolidone in veterinary medicines 14 apríl 2023NewsVeterinaryPharmacovigilanceReferrals New features further strengthen Priority Medicines scheme (PRIME) 4 apríl 2023NewsHumanMedicinesResearch and development EMA business hours over Easter holiday 4 apríl 2023NewsCorporate EU recommendations for 2023-2024 seasonal flu vaccine composition 4 apríl 2023NewsHumanVaccines 1 … 31 32 33 34 35 Page 35 of 383 36 37 38 39 … 383
First vaccine to protect older adults from respiratory syncytial virus (RSV) infection 26 apríl 2023NewsHumanMedicinesVaccines
EMA business hours over King's Day and Labour Day, 27 April and 1 May 25 apríl 2023NewsHumanCorporate
European Immunization Week 2023: Statement by Executive Director Emer Cooke - Routine vaccination matters! Every dose counts to stay protected 24 apríl 2023NewsHumanVaccines
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 18-20 April 2023 21 apríl 2023NewsVeterinaryMaximum residue limitMedicines
Single-arm trials as pivotal evidence for the authorisation of medicines in the EU 21 apríl 2023NewsHumanData on medicinesMedicines
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 11-14 April 2023 14 apríl 2023NewsHumanPharmacovigilanceReferrals
Reducing risks to human and animal health from exposure to N-methyl pyrrolidone in veterinary medicines 14 apríl 2023NewsVeterinaryPharmacovigilanceReferrals
New features further strengthen Priority Medicines scheme (PRIME) 4 apríl 2023NewsHumanMedicinesResearch and development